CyndRx Announces FDA Approval of AbsorbaSeal™ Vascular Closure Device June 5, 2026/in Featured/by cyndrx2026
CyndRx has begun enrollment in the SEAL TO HEAL U.S. IDE clinical trial to assess the safety and effectiveness of the AbsorbaSeal™ 5.6.7F Vascular Closure Device. May 31, 2022/in News/by cyndrx2026
CyndRx, LLC Receives Full FDA Approval of Investigational Device Exemption (IDE) to Initiate a U.S. Pivotal Trial for the AbsorbaSeal™ 5.6.7F Vascular Closure Device February 9, 2022/in News/by cyndrx2026
CyndRx, LLC Finalizes CE Mark Trial with Strong Clinical Outcomes using AbsorbaSeal™ Vascular Closure Device March 30, 2021/in News/by cyndrx2026
CyndRx, LLC Announces Completion of Enrollment in the AbsorbaSeal™ Vascular Closure Device CE Mark Trial December 11, 2020/in News/by cyndrx2026
CyndRx, LLC Enrolls First Patients in the AbsorbaSeal™ Vascular Closure Device CE Mark Trial October 7, 2020/in News/by cyndrx2026
